Sugril

Sugril

glibenclamide

Manufacturer:

Siam Bheasach

Distributor:

Siam Pharmaceutical
Concise Prescribing Info
Contents
Glibenclamide
Indications/Uses
NIDDM.
Dosage/Direction for Use
Initially 2.5 mg daily, increasing by 2.5 mg every 3-5 days until diabetic control is obtained. Max daily dose: 15 mg. Max single dose: 10 mg.
Administration
Should be taken with food.
Contraindications
IDDM. Patients w/ ketoacidosis, severe infections, stress, trauma. Severe renal, hepatic or thyroid impairment. Acute porphyria.
Special Precautions
Elderly. Excessive exercise. Hypoglycemia.
Adverse Reactions
Cholestatic jaundice. Allergic dermatologic & hematologic reactions. GI disturbances, metallic taste. Headache, dizziness, paresthesia.
Drug Interactions
Potentiation of hypoglycemia by chloramphenicol, sulfonamides, coumarin, NSAIDs, salicylates, clofibrate & cimetidine. Hypoglycemic effect decreased by rifampicin, thiazide diuretics, corticosteroids, OC & β-blockers.
MIMS Class
ATC Classification
A10BB01 - glibenclamide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Sugril tab 5 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in